• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较 HPV 在 HNSCC 患者中的流行情况与地域和社会经济因素的关系。

Comparison of HPV prevalence in HNSCC patients with regard to regional and socioeconomic factors.

机构信息

Institute of Pathology, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany,

出版信息

Eur Arch Otorhinolaryngol. 2014 Jun;271(6):1737-45. doi: 10.1007/s00405-013-2693-8. Epub 2013 Sep 25.

DOI:10.1007/s00405-013-2693-8
PMID:24065189
Abstract

HPV infection is considered as an independent risk factor for head and neck squamous cell carcinomas (HNSCC). Due to highly variable prevalence results in numerous studies, it is, however, difficult to estimate the relevance of HPV infection as risk factor for a specific patient collective. This study aimed to elucidate the disparities of HPV prevalence by analyzing socioeconomically and regionally different patient collectives. Two age, gender, stage and tumor location matched cohorts of 18 private health insured (PHIP) and 16 statutory health insured patients (SIP) suffering from an oropharyngeal squamous cell carcinoma (OSCC) and treated at a university hospital were screened for p16 overexpression and HPV infection by immunohistochemistry and PCR. In addition 85 HNSCC patients of an otolaryngology private practice (PPP) in a rural area were screened for p16 overexpression and positive cases were tested for HPV infection. HPV prevalence was 72.2% in the PHIP collective in comparison to 25.0% (p = 0.015) in the SIP collective with a significantly improved 5-year overall survival (p = 0.003) of the PHIP collective. The total HPV prevalence of PPP group was 7.1% with the highest infection rate in tonsillar carcinomas (33.3%) and a larger percentage of female patients in the HPV positive group (p = 0.037). This study shows that variable HPV infection rates in HNSCC can be caused by the selection of particular patient collectives, which suggest taking socioeconomic and regional factors into account for a decision on HPV testing, if it is not performed on a routine basis.

摘要

HPV 感染被认为是头颈部鳞状细胞癌(HNSCC)的一个独立危险因素。然而,由于在许多研究中 HPV 感染的流行率存在很大差异,因此很难评估 HPV 感染对特定患者群体的相关性。本研究旨在通过分析社会经济和地域差异的患者群体,阐明 HPV 流行率的差异。我们分析了 18 名私人医疗保险(PHIP)和 16 名法定医疗保险(SIP)的年龄、性别、分期和肿瘤位置匹配的口咽鳞状细胞癌(OSCC)患者,他们在大学医院接受治疗,并通过免疫组化和 PCR 分析筛选 p16 过表达和 HPV 感染。此外,我们还对农村地区耳鼻喉科私人诊所(PPP)的 85 名 HNSCC 患者进行了 p16 过表达筛选,对阳性病例进行了 HPV 感染检测。PHIP 组 HPV 流行率为 72.2%,而 SIP 组为 25.0%(p = 0.015),PHIP 组的 5 年总生存率显著提高(p = 0.003)。PPP 组 HPV 总流行率为 7.1%,其中扁桃体癌感染率最高(33.3%),HPV 阳性组中女性患者比例较高(p = 0.037)。本研究表明,HNSCC 中 HPV 感染率的差异可能是由于选择了特定的患者群体所致,这表明如果不是常规进行 HPV 检测,则应考虑社会经济和地域因素,以决定是否进行 HPV 检测。

相似文献

1
Comparison of HPV prevalence in HNSCC patients with regard to regional and socioeconomic factors.比较 HPV 在 HNSCC 患者中的流行情况与地域和社会经济因素的关系。
Eur Arch Otorhinolaryngol. 2014 Jun;271(6):1737-45. doi: 10.1007/s00405-013-2693-8. Epub 2013 Sep 25.
2
Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer.人乳头瘤病毒的流行率与扁桃体或舌根以外的口咽癌的生存率。
Cancer Med. 2012 Aug;1(1):82-8. doi: 10.1002/cam4.2. Epub 2012 Jun 3.
3
Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.扁桃体癌和舌根癌中HPV DNA/p16双阳性可改善预后:一项基于大规模人群研究的见解
Int J Cancer. 2016 Dec 1;139(11):2598-605. doi: 10.1002/ijc.30389. Epub 2016 Aug 30.
4
HPV-Positive Oropharyngeal Cancer Via p16 Immunohistochemistry in Japan.日本通过p16免疫组化检测的人乳头瘤病毒阳性口咽癌
Ann Otol Rhinol Laryngol. 2017 Feb;126(2):152-158. doi: 10.1177/0003489416681582.
5
Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.头颈部癌中人乳头瘤病毒(HPV)感染的患病率存在地域差异:一项来自巴西和德国的比较研究。
Virchows Arch. 2015 Jun;466(6):685-93. doi: 10.1007/s00428-015-1761-4. Epub 2015 Mar 28.
6
Study of the concordance between p16 immunohistochemistry and HPV-PCR genotyping for the viral diagnosis of oropharyngeal squamous cell carcinoma.p16免疫组化与HPV-PCR基因分型在口咽鳞状细胞癌病毒诊断中的一致性研究
Eur Ann Otorhinolaryngol Head Neck Dis. 2015 Jun;132(3):135-9. doi: 10.1016/j.anorl.2015.01.003. Epub 2015 Feb 14.
7
Changing trends in human papillomavirus-associated head and neck squamous cell carcinoma.人乳头瘤病毒相关头颈部鳞状细胞癌的变化趋势。
Ann Diagn Pathol. 2012 Jan;16(1):7-12. doi: 10.1016/j.anndiagpath.2011.07.003. Epub 2011 Oct 15.
8
Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.泰国 p16 阳性 HPV 相关头颈部癌症的低流行率:三级转诊中心经验。
BMC Cancer. 2019 Nov 6;19(1):1050. doi: 10.1186/s12885-019-6266-0.
9
Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.由人乳头瘤病毒和表皮生长因子受体状态所确定的分子亚分类与口咽鳞状细胞癌的预后相关。
Hum Pathol. 2016 Apr;50:51-61. doi: 10.1016/j.humpath.2015.11.001. Epub 2015 Nov 17.
10
The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.从 2000 年到 2010 年,在一家综合性癌症中心,利用多重插补法改变人乳头瘤病毒相关性口咽癌的发病率。
Cancer Epidemiol. 2013 Dec;37(6):820-9. doi: 10.1016/j.canep.2013.09.011. Epub 2013 Nov 1.

引用本文的文献

1
Influence of Rurality on Oral Cancer Trends among Organisation for Economic Co-Operation and Development (OECD) Member Countries-A Scoping Review.农村地区对经济合作与发展组织(OECD)成员国口腔癌趋势的影响——一项范围综述
Cancers (Basel). 2024 Aug 24;16(17):2957. doi: 10.3390/cancers16172957.
2
Investigation of Machine and Deep Learning Techniques to Detect HPV Status.用于检测人乳头瘤病毒(HPV)状态的机器和深度学习技术研究
J Pers Med. 2024 Jul 10;14(7):737. doi: 10.3390/jpm14070737.
3
Socio-Economic Position, Cancer Incidence and Stage at Diagnosis: A Nationwide Cohort Study in Belgium.

本文引用的文献

1
Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis.人乳头瘤病毒相关头颈部癌症的生存:系统评价和荟萃分析。
Oral Oncol. 2012 Dec;48(12):1191-201. doi: 10.1016/j.oraloncology.2012.06.019. Epub 2012 Jul 28.
2
Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma?p16 免疫组化染色法是否是一种更具成本效益的方法,用于鉴定人乳头瘤病毒相关的头颈部鳞状细胞癌?
Ann Diagn Pathol. 2012 Apr;16(2):91-9. doi: 10.1016/j.anndiagpath.2011.09.002. Epub 2011 Dec 23.
3
Changing trends in human papillomavirus-associated head and neck squamous cell carcinoma.
社会经济地位、癌症发病率及诊断时的分期:比利时一项全国性队列研究
Cancers (Basel). 2021 Feb 24;13(5):933. doi: 10.3390/cancers13050933.
4
In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation.计算机分析显示 EP300 通过代谢调节成为一种泛癌的抗肿瘤免疫反应抑制剂。
Sci Rep. 2020 Jun 10;10(1):9389. doi: 10.1038/s41598-020-66329-7.
5
APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma.APOBEC 诱导的突变及其对头颈鳞状细胞癌的癌症效应大小。
Oncogene. 2019 May;38(18):3475-3487. doi: 10.1038/s41388-018-0657-6. Epub 2019 Jan 15.
6
Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study.基于标准CT影像预测HPV(p16)状态的影像组学特征的开发与验证:一项多中心研究
Br J Radiol. 2018 Jun;91(1086):20170498. doi: 10.1259/bjr.20170498. Epub 2018 Mar 22.
7
Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma.迈向精准医学在头颈部鳞状细胞癌治疗中的应用。
Oncotarget. 2017 Jan 10;8(2):2141-2152. doi: 10.18632/oncotarget.13798.
8
Classification of TP53 mutations and HPV predict survival in advanced larynx cancer.TP53突变和人乳头瘤病毒(HPV)的分类可预测晚期喉癌的生存率。
Laryngoscope. 2016 Sep;126(9):E292-9. doi: 10.1002/lary.25915. Epub 2016 Jun 27.
9
Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different.HPV 阴性和 HPV 阳性头颈部鳞状细胞癌的免疫和代谢特征有显著差异。
Virchows Arch. 2014 Sep;465(3):299-312. doi: 10.1007/s00428-014-1630-6. Epub 2014 Jul 16.
人乳头瘤病毒相关头颈部鳞状细胞癌的变化趋势。
Ann Diagn Pathol. 2012 Jan;16(1):7-12. doi: 10.1016/j.anndiagpath.2011.07.003. Epub 2011 Oct 15.
4
Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice.评估人乳头瘤病毒检测在临床实践中对扁桃体鳞癌的应用。
J Clin Pathol. 2011 Apr;64(4):308-12. doi: 10.1136/jcp.2010.088450. Epub 2011 Feb 23.
5
HPV involvement in tonsillar cancer: prognostic significance and clinically relevant markers.HPV 与扁桃体癌的关系:预后意义和有临床意义的标志物。
Int J Cancer. 2011 Jul 1;129(1):101-10. doi: 10.1002/ijc.25889. Epub 2011 Apr 13.
6
The molecular biology of head and neck cancer.头颈部癌症的分子生物学。
Nat Rev Cancer. 2011 Jan;11(1):9-22. doi: 10.1038/nrc2982. Epub 2010 Dec 16.
7
The role of human papillomavirus infection in head and neck cancers.人乳头瘤病毒感染在头颈部癌症中的作用。
Ann Oncol. 2010 Oct;21 Suppl 7:vii243-5. doi: 10.1093/annonc/mdq454.
8
Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).人乳头瘤病毒(HPV)对头颈部鳞状细胞癌(HNSCC)的癌症风险和总生存率影响的荟萃分析。
Head Neck Oncol. 2010 Jun 29;2:15. doi: 10.1186/1758-3284-2-15.
9
Human papillomavirus and survival of patients with oropharyngeal cancer.人乳头瘤病毒与口咽癌患者的生存。
N Engl J Med. 2010 Jul 1;363(1):24-35. doi: 10.1056/NEJMoa0912217. Epub 2010 Jun 7.
10
p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters.p16 在口咽癌中的表达:与传统临床分期参数相比,其对分期和预后的影响。
Ann Oncol. 2010 Oct;21(10):1961-1966. doi: 10.1093/annonc/mdq210. Epub 2010 Apr 27.